Crosstex acquires NAMSA's sterility assurance products division: further expands sterility assurance portfolio and broadens market diversification.
HAUPPAUGE, NY -- February 3, 2016--Crosstex has entered into a definitive agreement with North American Science Associates, Inc. (NAMSA) to acquire their Sterility Assurance Monitoring Products division. This division manufactures a broad suite of high-quality biological and chemical indicators which are used to accurately monitor the effectiveness of sterilization processes. These indicators are designed primarily for the industrial segment serving medical device, life science and other manufacturers, representing a new end-market for Crosstex.
Gary Steinberg, President and CEO of Crosstex said, "This acquisition not only allows us to expand our sterility assurance product offering, but also broadens our presence into the important industrial market segment. We are also excited to provide additional product solutions to these customers with Crosstex's complete infection prevention product portfolio."
John Hughes, Vice President/General Manager of Crosstex/SPSmedical in Rochester, NY stated, "The addition of NAMSA's Sterility Assurance Products Division expands our market position in the biological and chemical integrator market while strengthening our manufacturing capabilities through greater vertical integration." Hughes went on to say, "We have retained the sales, marketing and customer care team which will allow for a seamless transition and provide our new customers with the same level of service and support they have been accustomed to receiving."
Subject to customary closing conditions, the transaction is expected to close in the 3rd quarter of our Fiscal Year 2016.
Crosstex, a Cantel Medical company, manufactures a wide array of unique and innovative infection prevention and compliance products for the global healthcare industry. Founded in 1953 and headquartered in Hauppauge, New York, Crosstex is a recognized leader for its portfolio of waterline treatment, biological monitoring, sterility assurance packaging and person protection equipment (PPE).
Sold in more than 100 countries, the range of products distributed to medical, dental and veterinary practices and facilities include our award winning (5 consecutive years) Secure Fit technology face masks, DentaPure waterline treatment cartridges and Sterilex Liquid Ultra, Sure-Check sterilization pouches with internal/external multi-parameter indicators, Tyvek pouches with 510K approval, SteamPlus Type 5 chemical integrators, ConFirm and Passport Plus in-office and mail-in biological indicators, Rapicide OPA/28 high level disinfectant.
For information on the full line of Crosstex infections prevention and compliance products, please contact Crosstex at 631-582-6777 or visit www.crosstex.com.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||PRESS RELEASE; North American Science Associates|
|Publication:||The Dental Assistant|
|Date:||Mar 1, 2016|
|Previous Article:||Gelato prophy paste wins top prophy paste award for fourth consecutive year.|
|Next Article:||CDC estimate: high periodontal disease prevalence found among Southern U.S. States: highest incidence found in New Mexico, Hawaii: New Data...|